RUSSU, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 732
EU - Europa 493
AS - Asia 343
SA - Sud America 4
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.577
Nazione #
US - Stati Uniti d'America 725
CN - Cina 325
IE - Irlanda 182
UA - Ucraina 98
FI - Finlandia 58
DE - Germania 47
SE - Svezia 35
GB - Regno Unito 31
IT - Italia 15
SG - Singapore 14
BE - Belgio 12
CA - Canada 7
FR - Francia 7
BR - Brasile 4
PL - Polonia 3
RU - Federazione Russa 3
AU - Australia 2
JP - Giappone 2
MU - Mauritius 2
PT - Portogallo 2
EU - Europa 1
IN - India 1
KR - Corea 1
Totale 1.577
Città #
Chandler 183
Dublin 182
Jacksonville 120
Nanjing 82
Beijing 65
Ann Arbor 52
Nanchang 35
Wilmington 33
Ashburn 30
Princeton 27
Jiaxing 25
Shenyang 24
Dearborn 23
Lawrence 22
Tianjin 22
Boardman 19
Hebei 18
Shanghai 16
Medford 15
Changsha 14
Houston 13
Brussels 12
Helsinki 11
Los Angeles 11
Singapore 11
Milan 8
Woodbridge 8
Hangzhou 7
New York 6
Toronto 6
Kunming 5
Norwalk 5
Chicago 4
Pavia 4
Seattle 4
Fairfield 3
Falls Church 3
Krakow 3
Lanzhou 3
Redwood City 3
Saint Petersburg 3
Washington 3
Coimbra 2
Des Moines 2
Jinan 2
Ningbo 2
Perth 2
Piscataway 2
Tokyo 2
Changchun 1
Dallas 1
Dolo 1
Garching 1
Hefei 1
Newton 1
Pune 1
Redmond 1
San Francisco 1
Seocho-gu 1
Sunnyvale 1
Surrey 1
Tappahannock 1
Verona 1
Xian 1
Totale 1.172
Nome #
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 87
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 86
Continuous-time Markov modelling of flexible-dose depression trials 78
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 76
Modeling myelosuppression in patients treated with anticancer drugs 73
Bayesian population approaches to the analysis of dose escalation studies 71
Heart rate correction of the QT interval: a nonparametric individualized approach 68
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 68
A state-space approach to disease and dropout modelling in Phase II clinical trials 67
Second order Markov modelling of HAMD responses in depression trials 66
Dose escalation studies: a comparison among Bayesian models 65
Population state-space modelling of patient responses in antidepressant studies 65
Statistical methods to detect immune responses to drug administration 63
A PCA approach to population analysis: with application to a Phase II depression trial 62
Stochastic model search with binary outcomes for genome-wide association studies. 61
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 59
Modelling of the outcome of non-inferiority trials by integration of historical data 56
Disease and dropout modelling in depression trials: a state-space approach 55
Joint Modeling of Efficacy, Dropout, and Tolerability in Flexible-Dose Trials: A Case Study in Depression 55
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 54
Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response 49
A new, second-order indirect model of depression time course 44
Population modelling of patient responses in antidepressant studies: A stochastic approach 41
Bayesian population modelling of Phase I dose escalation studies: Gaussian process vs parametric approaches 40
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 40
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 37
Totale 1.586
Categoria #
all - tutte 5.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020412 98 125 2 21 4 20 1 44 15 38 43 1
2020/2021194 23 19 7 22 1 26 5 24 6 29 26 6
2021/2022120 3 2 6 2 4 5 4 8 12 4 16 54
2022/2023489 41 52 10 36 48 48 0 20 211 7 11 5
2023/2024149 21 25 5 11 10 33 7 13 0 11 5 8
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.586